Maravai LifeSciences Holdings Inc
(NAS:MRVI)
$
5.92
0.3 (5.34%)
Market Cap: 839.71 Mil
Enterprise Value: 780.08 Mil
PE Ratio: 0
PB Ratio: 2.43
GF Score: 74/100 Maravai LifeSciences Holdings Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022 / 09:40PM GMT
Release Date Price:
$26.33
(+1.07%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs, and the pleasure of welcoming Maravai Life Sciences here this afternoon. Kevin Herde, the Executive Vice President and CFO. Kevin, thank you very much for joining us today.
Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO
Great. Thanks, Matt.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe you could just set the stage and talk a little bit about the most recent quarter. Your guidance for the year and kind of how you see trends in the bioprocessing market evolving longer term? And we can get more into that last part, but sort of some of the highlights from the quarter and then what do you expect for the year?
Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO
Yes, certainly
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot